Orega Biotech
Records under this name other than the patents Orega Biotech holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 4 of 4 · Back to Orega Biotech
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,834,601 | Antagonists of IL-17 Isoforms and Their Uses Formerly held In force · High confidence | In force | High confidence | |
| US 10,351,623 | Antagonists of IL-17 Isoforms and Their Uses Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,377,503 | Antibodies That Bind Human CD39 and Inhibit Atpase Activity of a Soluble Extracellular Domain Human CD39 Polypeptide Formerly held In force · High confidence | In force | High confidence | |
| US 9,676,847 | IL-17 Antagonist Antibodies Formerly held Lapsed on the fee record Ended Jun 13, 2025 · High confidence | Lapsed on the fee record | Ended Jun 13, 2025 | High confidence |